This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Jul;48(1):130-1.

Weight loss in Huntington's disease

N Stoy, E McKay

PMID: 10894233

Comment

Weight loss in Huntington's disease

N Stoy et al. Ann Neurol. 2000 Jul.

. 2000 Jul;48(1):130-1.

Authors

N Stoy, E McKay

PMID: 10894233

No abstract available

PubMed Disclaimer

Comment on

Higher sedentary energy expenditure in patients with Huntington's disease.
Pratley RE, Salbe AD, Ravussin E, Caviness JN. Pratley RE, et al. Ann Neurol. 2000 Jan;47(1):64-70. Ann Neurol. 2000. PMID: 10632102

Similar articles

Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
Björkqvist M, Leavitt BR, Nielsen JE, Landwehrmeyer B, Ecker D, Mulder H, Brundin P, Petersén A. Björkqvist M, et al. Mov Disord. 2007 Oct 15;22(13):1952-4. doi: 10.1002/mds.21447. Mov Disord. 2007. PMID: 17722045
Therapeutic approach in Huntington's disease.
Durr A. Durr A. Handb Clin Neurol. 2008;89:631-8. doi: 10.1016/S0072-9752(07)01258-4. Handb Clin Neurol. 2008. PMID: 18631784 No abstract available.
Arithmetic word-problem-solving in Huntington's disease.
Allain P, Verny C, Aubin G, Pinon K, Bonneau D, Dubas F, Le Gall D. Allain P, et al. Brain Cogn. 2005 Feb;57(1):1-3. doi: 10.1016/j.bandc.2004.08.010. Brain Cogn. 2005. PMID: 15629205 Clinical Trial.
Hypocretin-1 and secondary signs in Huntington's disease.
Roos RA, Aziz NA. Roos RA, et al. Parkinsonism Relat Disord. 2007;13 Suppl 3:S387-90. doi: 10.1016/S1353-8020(08)70035-X. Parkinsonism Relat Disord. 2007. PMID: 18267269 Review.
Animal models of Huntington's disease.
Gárdián G. Gárdián G. Ideggyogy Sz. 2006 Nov 20;59(11-12):396-9. Ideggyogy Sz. 2006. PMID: 17203874 Review.

See all similar articles

Cited by

Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.
Ayala-Peña S. Ayala-Peña S. Free Radic Biol Med. 2013 Sep;62:102-110. doi: 10.1016/j.freeradbiomed.2013.04.017. Epub 2013 Apr 18. Free Radic Biol Med. 2013. PMID: 23602907 Free PMC article. Review.
How vital is sleep in Huntington's disease?
Goodman AO, Barker RA. Goodman AO, et al. J Neurol. 2010 Jun;257(6):882-97. doi: 10.1007/s00415-010-5517-4. Epub 2010 Mar 24. J Neurol. 2010. PMID: 20333394 Review.
A novel and accurate full-length HTT mouse model for Huntington's disease.
Shenoy SA, Zheng S, Liu W, Dai Y, Liu Y, Hou Z, Mori S, Tang Y, Cheng J, Duan W, Li C. Shenoy SA, et al. Elife. 2022 Jan 13;11:e70217. doi: 10.7554/eLife.70217. Elife. 2022. PMID: 35023827 Free PMC article.
Analysis of metabolic effects of menthol on WFS1-deficient mice.
Ehrlich M, Ivask M, Raasmaja A, Kõks S. Ehrlich M, et al. Physiol Rep. 2016 Jan;4(1):e12660. doi: 10.14814/phy2.12660. Physiol Rep. 2016. PMID: 26733243 Free PMC article.
Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle.
Hernández-Echeagaray E, González N, Ruelas A, Mendoza E, Rodríguez-Martínez E, Antuna-Bizarro R. Hernández-Echeagaray E, et al. Neurol Sci. 2011 Apr;32(2):241-54. doi: 10.1007/s10072-010-0394-2. Epub 2010 Aug 24. Neurol Sci. 2011. PMID: 20734097

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information